Korean traditional Chungkookjang improves body composition, lipid profiles and atherogenic indices in overweight/obese subjects: a double-blind, randomized, crossover, placebo-controlled clinical trial

被引:39
|
作者
Byun, M-S [1 ,2 ]
Yu, O-K [1 ]
Cha, Y-S [1 ,2 ]
Park, T-S [1 ,3 ]
机构
[1] Chonbuk Natl Univ, Dept Obes Res Ctr, Jeonju, South Korea
[2] Chonbuk Natl Univ, Dept Food Sci & Human Nutr, 664-14 Duckjin Dong, Jeonju 561756, Jeonbuk, South Korea
[3] Chonbuk Natl Univ, Dept Internal Med, Div Endocrinol & Metab, Sch Med, Jeonju, South Korea
关键词
SOY-PROTEIN; MYOCARDIAL-INFARCTION; APOLIPOPROTEIN-B; OBESE SUBJECTS; RISK MARKERS; WEIGHT-LOSS; CHOLESTEROL; ATHEROSCLEROSIS; SUPPLEMENTATION; DYSLIPIDEMIA;
D O I
10.1038/ejcn.2016.77
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
BACKGROUND/OBJECTIVES: Chungkookjang is a Korean representative fermented soybean food. In this study, we investigated the effect of Korean traditional Chungkookjang compared with placebo on body composition, dyslipidemia and risk factors for atherosclerosis in overweight/obese subjects. SUBJECTS/METHODS: This double-blind, randomized, controlled crossover trial was conducted on 120 overweight/obese subjects, aged 19-29 years. Subjects were randomly divided into a Chungkookjang (n = 60) or a placebo (n = 60) group. After 12 weeks, the groups were crossed over for an additional 12 weeks. During the intervention period, subjects were asked to maintain their usual diet and activity and not to take any functional foods or dietary supplements. The anthropometric measures, lipid profiles and atherogenic indices were determined at baseline and at the end of each 12-week period. RESULTS: The anthropometry measurements, percentage body fat, lean body mass, waist circumference and waist-to-hip ratio of women in the Chungkookjang group were significantly improved compared with the placebo group. Lipid profiles and high-sensitivity C-reactive protein of women in Chungkookjang were significantly improved. The atherogenic indices of apolipoprotein B/apolipoprotein A1 decreased in both the placebo and the Chungkookjang group, and it also decreased below 0.55 for all the men and women in the Chungkookjang group. CONCLUSIONS: In conclusion, these results suggest that supplementation with Chungkookjang may improve body composition and risk factors for cardiovascular disease in overweight and obese adults.
引用
收藏
页码:1116 / 1122
页数:7
相关论文
共 50 条
  • [41] Effect of oligofructose supplementation on body weight in overweight and obese children: a randomised, double-blind, placebo-controlled trial
    Liber, Anna
    Szajewska, Hania
    BRITISH JOURNAL OF NUTRITION, 2014, 112 (12) : 2068 - 2074
  • [42] Vitamin D supplementation improves SIRT1, Irisin, and glucose indices in overweight or obese type 2 diabetic patients: a double-blind randomized placebo-controlled clinical trial
    Peivasteh Safarpour
    Milad Daneshi-Maskooni
    Mohammadreza Vafa
    Mitra Nourbakhsh
    Leila Janani
    Mohsen Maddah
    Fatemeh-Sadat Amiri
    Fereshteh Mohammadi
    Homa Sadeghi
    BMC Family Practice, 21
  • [43] Antiobesity effect of Pediococcus pentosaceus LP28 on overweight subjects: a randomized, double-blind, placebo-controlled clinical trial
    Higashikawa, F.
    Noda, M.
    Awaya, T.
    Danshiitsoodol, N.
    Matoba, Y.
    Kumagai, T.
    Sugiyama, M.
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2016, 70 (05) : 582 - 587
  • [44] Mangiferin supplementation improves serum lipid profiles in overweight patients with hyperlipidemia: a double-blind randomized controlled trial
    Lixin Na
    Qiao Zhang
    Shuo Jiang
    Shanshan Du
    Wei Zhang
    Ying Li
    Changhao Sun
    Yucun Niu
    Scientific Reports, 5
  • [45] Mangiferin supplementation improves serum lipid profiles in overweight patients with hyperlipidemia: a double-blind randomized controlled trial
    Na, Lixin
    Zhang, Qiao
    Jiang, Shuo
    Du, Shanshan
    Zhang, Wei
    Li, Ying
    Sun, Changhao
    Niu, Yucun
    SCIENTIFIC REPORTS, 2015, 5
  • [46] Saccharomyces boulardii improves clinical and paraclinical indices in overweight/obese knee osteoarthritis patients: a randomized triple-blind placebo-controlled trial
    Dolatkhah, Neda
    Jafari, Alireza
    Eslamian, Fariba
    Toopchizadeh, Vahideh
    Saleh, Parviz
    Hashemian, Maryam
    EUROPEAN JOURNAL OF NUTRITION, 2024, 63 (06) : 2291 - 2305
  • [47] Effects of probiotics on selected anthropometrics and biochemical measures in overweight or obese Saudi subjects: a double-blind, placebo-controlled, randomised clinical trial
    AlMalki, Samira M.
    Alfawaz, Hanan A.
    Binmoammar, Turki A.
    AlBahlei, Saleh F.
    Al Bakr, Luluah M.
    Alzahrani, Ahmed M.
    Alshammari, Salem S.
    Hussain, Syed Danish
    Sabico, Shaun
    Al-Daghri, Nasser M.
    PUBLIC HEALTH NUTRITION, 2024, 27 (01)
  • [48] Treatment of chronic constipation with colchicine: Randomized, double-blind, placebo-controlled, crossover trial
    Verne, GN
    Davis, RH
    Robinson, ME
    Gordon, JM
    Eaker, EY
    Sninksy, CA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (05): : 1112 - 1116
  • [49] Randomized, double-blind, placebo-controlled crossover trial of Famotidine in patients with functional dyspepsia
    Kato, Mototsugu
    Yoshida, Takeshi
    Hata, Tamotsu
    Ono, Yuji
    Ono, Shouko
    Nakagawa, Manabu
    Nakagawa, Souichi
    Shimizu, Yuichi
    Asaka, Masahiro
    GASTROENTEROLOGY, 2006, 130 (04) : A158 - A158
  • [50] Improvement of erectile function with Prelox: a randomized, double-blind, placebo-controlled, crossover trial
    R Stanislavov
    V Nikolova
    P Rohdewald
    International Journal of Impotence Research, 2008, 20 : 173 - 180